VanEck Biotech ETF
BBH
BBH
79 hedge funds and large institutions have $249M invested in VanEck Biotech ETF in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
18.06% less ownership
Funds ownership: 52.71% → 34.65% (-18%)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
79
Holding in Top 10
–
Calls
$4.94M
Puts
$1.53M
Top Buyers
| 1 | +$14.5M | |
| 2 | +$2.38M | |
| 3 | +$1.67M | |
| 4 |
CCA
Conservest Capital Advisors
Wynnewood,
Pennsylvania
|
+$1.37M |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$248K |
Top Sellers
| 1 | -$1.76M | |
| 2 | -$1.12M | |
| 3 | -$1.07M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$966K |
| 5 |
TBA
Train Babcock Advisors
New York
|
-$782K |